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Aldehyde dehydrogenase (ALDH) genes are increasingly associated with stem/progenitor cell status but
their role in the maintenance of pluripotency remains uncertain. In a screen conducted for downstream
Ngn3 target genes using ES derived pancreas progenitors we identiﬁed Aldh1b1, encoding a mitochon-
drial enzyme, as one of the genes strongly up regulated in response to Ngn3 expression. We found both
by in situ hybridization and immunoﬂuorescence using a speciﬁc antibody that ALDH1B1 is exclusively
expressed in the emerging pancreatic buds of the early embryo (9.5 dpc) in a Pdx1 dependent manner.
Around the time of secondary transition, ALDH1B1 expression was restricted in the tip tripotent
progenitors of the branching epithelium and in a subset of the trunk epithelium. Expression in the latter
was Ngn3 dependent. Subsequently, ALDH1B1 expression persisted only in the tip cells that become
restricted to the exocrine lineage and declined rapidly as these cells mature. In the adult pancreas we
identiﬁed rare ALDH1B1þ cells that become abundant following pancreas injury in either the caerulein
or streptozotocin paradigms. Blocking ALDH catalytic activity in pancreas embryonic explants resulted
in reduced size of the explants and accelerated differentiation suggesting for the ﬁrst time that
ALDH activity may be necessary in the developing pancreas for the maintenance and expansion of
progenitor pools.
& 2012 Elsevier Inc. All rights reserved.Introduction
The identiﬁcation of stem/progenitor cell markers, particularly
in adult tissues, is an important goal for regenerative medicine.
Identiﬁcation of speciﬁc markers for stem/progenitor cells is
essential for their isolation and study as well as for the enrich-
ment of ES cell or iPS cell derived populations for speciﬁc stem/
progenitor cells. In the pancreas, the question of whether multi-
potent pancreatic progenitors persist into adulthood, as well as
their possible anatomical location have been highly contested
issues.
Genetic lineage tracing based on CRE recombinase and
combined with functional analyses using a variety of pancreas
injury and regeneration models have not yet pinpointed an adult
progenitor cell for all pancreatic lineages (Furuyama et al., 2011;ll rights reserved.
stitute Dresden, Center for
niversity of Technology,
resden.de,Inada et al., 2008; Kopinke et al., 2011; Kopinke and Murtaugh,
2010; Kopp et al., 2011b; Solar et al., 2009). Obviously, this does
not exclude the possibility that an as yet unknown gene may
speciﬁcally mark such pancreas stem/progenitor cells. Addition-
ally, unidentiﬁed extracellular signals may be necessary for the
expansion, survival and differentiation of stem/progenitor cells
following injury and regeneration. The conﬂicting results regard-
ing the presence of progenitor cells and their differentiation
potential may be indicative of the presence of the required
signal(s) in sub-optimal concentrations. Furthermore, bona ﬁde
stem/progenitor cells may not be identiﬁable by the expression of
a single gene but by the combinatorial expression of several
genes, possibly speciﬁc transcription factors (Kopp et al., 2011a).
In this case only the development and use of highly sophisticated
lineage tracing methods will allow the unambiguous identiﬁca-
tion of this population. Genes strongly expressed in progenitor
pools during development are prime candidates as markers for
adult stem/progenitor cells. Ideal markers should allow the
isolation of the target cell population with minimal damage and
be highly speciﬁc to allow for unambiguous lineage tracing of
descendant cells.
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deﬁnitive endoderm and is ﬁrst morphologically obvious around
9.5 dpc with the emergence of the dorsal and ventral pancreatic
buds (Spooner et al., 1970). Induction of the pancreatic fates is
mediated from signals emanating from the adjacent mesodermal,
notochord and dorsal aorta tissues. Retinoic acid (RA), FGF and
BMP signaling and inhibition of SHH signaling (Dessimoz et al.,
2006; Hebrok et al., 1998; Kim and Melton, 1998; Kumar et al.,
2003; Martin et al., 2005; Molotkov et al., 2005; Stafford and
Prince, 2002; Wells and Melton, 2000) play key roles in the
emergence of the pancreatic primordia. All pancreatic cell types
are derived from this pool of early pancreatic progenitor cells that
co-express the transcription factors PDX1, PTF1a and SOX9
(Kawaguchi et al., 2002; Seymour et al., 2007).
The pancreatic buds thicken and then start expanding at around
10.5 dpc by branching morphogenesis (Puri and Hebrok, 2007).
Successive rounds of branching and growth result in a tree-like
epithelial network surrounded by mesenchyme. As branching mor-
phogenesis proceeds, expression of Ptf1a and Cpa1 become restricted
to the tips of the branching epithelium. Lineage tracing suggest that
the tips retain their multipotentiality until 13.5 dpc, at which point
resident CPA1þ cells become dedicated acinar progenitors (Zhou
et al., 2007). The extension of the tips leaves behind trunk cells
expressing Nkx6.1, Nkx6.2, Sox9 and Hnf1b. Hnf1b is expressed
exclusively in all trunk cells and HNF1bþ cells remain multipotent
up until around 13.5 dpc. The reciprocal repression between Ptf1a and
Nkx6 transcription factors acts as a switch in multipotent progenitors
directing them to either the acinar or the ductal/endocrine fate
(Schaffer et al., 2010). This is reﬂected in the switch of themultipotent
trunk HNF1bþ cells to exclusive duct/endocrine progenitors cells
(Solar et al., 2009). NGN3þ endocrine progenitor cells arise from the
trunk epithelium, delaminate and migrate into the mesenchyme to
differentiate into the islet cells of the mature organ leaving behind
acinar progenitors (Cole et al., 2009; Gouzi et al., 2011; Rukstalis and
Habener, 2007).
Thus the emerging picture of stem/progenitor cells is a highly
dynamic one, whereby as cells mature and become restricted in their
developmental potential, expression of distinct transcription factors
segregates to different progenitor populations and then differentiated
cells. For example, based on its expression pattern in embryonic and
adult pancreas, but also on its unique expression in various stem/
progenitor cell domains (Kopp et al., 2011a), Sox9 was postulated as a
possible marker of stem/progenitor cells in the adult pancreas. Careful
lineage tracing analysis showed that whereas the Sox9þ cell domain
remains multipotent up until birth, this multipotency is rapidly lost
during the ﬁrst three weeks of age (Kopp et al., 2011b).
The existence of a small population of PDX1, PTF1a, SOX9 and
NKX6.1 co-positive cells at the interface of the tip and the trunk
regions raised the possibility that this population were the
precursors of the centro-acinar cells that are thought to represent
the facultative stem/progenitor cell of the adult pancreas (Kopp
et al., 2011a). ALDH activity is being increasingly associated with
stem/progenitor cell status (Balber, 2011). It is hypothesized that
this activity constitutes a signiﬁcant determinant of stem/pro-
genitor cell survival through its ability to detoxify metabolic
byproducts and potentially cytotoxic molecules (Alison et al.,
2010; Gasparetto et al., 2012), but this hypothesis has not been
genetically tested. Thus putative progenitor centroacinar cells
were isolated from adult pancreata on the basis of their high
aldehyde dehydrogenase (ALDH) activity and shown to generate
multiple pancreatic cell types in vitro or upon transplantation into
embryonic pancreas explants. Strong expression of the aldehyde
dehydrogenase genes Aldh1a1 and Aldh1a7 in this cell population
was demonstrated by qPCR, but the capacity of the isolated cells
to generate endocrine and exocrine cells was not directly asso-
ciated with Aldh1a1 and/or Aldh1a7 function. Using a broadspeciﬁcity (polyclonal) ALDH1 antibody, ALDH immunoreactivity,
restricted at the tips of the branching epithelium, was detected at
embryonic stages 12.5 dpc and 14.5 dpc (Rovira et al., 2010).
In a screen conducted for downstream NGN3 target genes using
ES derived pancreas progenitors we identiﬁed a novel aldehyde
dehydrogenease gene, Aldh1b1 (encoding a mitochondrial enzyme)
as one of the genes strongly up regulated in response to Ngn3
expression (Seraﬁmidis et al., 2008). We then found both by in situ
hybridization and immunoﬂuorescence using an ALDH1B1-speciﬁc
antibody (Stagos et al., 2010) that it is exclusively expressed in the
emerging pancreatic buds of the early embryo (9.5 dpc) in a Pdx1
dependent manner. Expression of Aldh1b1 and Aldh1a1 were the
strongest among expression of several Aldh genes examined around
the time of secondary transition. Expression of both genes dropped in
Ngn3 null 14.5 dpc pancreata suggesting that together they may play
a key role in the development of the epithelium and the endocrine
lineage in particular. Aldh1b1 expression was restricted in the tip
tripotent progenitors of the branching epithelium and in a subset of
the trunk epithelium. Expression in the latter was Ngn3 dependent.
Later, Aldh1b1 expression persisted only in the tip cells that are
restricted to the exocrine lineage and declined rapidly as these cells
matured. In the adult pancreas we identiﬁed rare ALDH1B1þ cells
that became abundant following pancreas injury and regeneration.
Blocking ALDH activity in pancreas embryonic explants resulted in
reduced size of the explants and accelerated differentiation, suggest-
ing for the ﬁrst time that ALDH activity may be necessary in the
developing pancreas for themaintenance and expansion of progenitor
pools.Materials and methods
Animal strains
Animal studies were conducted in accordance with interna-
tional guidelines and after ethical approval of the competent
Veterinary Service of Athens. Null mouse mutants were use for
the Ngn3 (Gradwohl et al., 2000), and the Pdx1 (Holland et al.,
2002) genes. Mouse genotyping procedures were as described for
Ngn3 (Gradwohl et al., 2000), and Pdx1 (Holland et al., 2002).
Real Time PCR
Six (12.5 dpc) or four (14.5 dpc) embryonic pancreata were
pooled. Total RNA isolation and cDNA preparation were according
to standard procedures (Seraﬁmidis et al., 2008). Real Time PCR
primers were designed using the Beacon Designer software, Real
Time PCR reactions were performed with SYBR-GREENER (Invi-
trogen) using an ABI PRISM 7000 machine and primary results
were analyzed using the machine’s software. Absolute expression
values were calculated using the DCt method (expression¼
2(Ct sampleCt bactin)) and multiplied by 1000. At least three
reactions for each gene at each time point were carried out.
Primers used were evaluated by inspection of the dissociation
curve and were as follows: Aldh1b1 F: AGCCTCTGTTCAAGTTCAAG,
R: CCTTAAAGCCTCCGAATGG, Aldh2 F: GTAGACAAGGCAGTGAAG,
R: GGTACGAGATGACATAAGG, Aldh1a1 F: TATATGATGTTGTCAG
CCCAGTG, R: ATGTTCACCCAGTTCTCTTCC, Aldh1a2 F: TGGAAATG
GGAGAGAAATGG, R: GGCAAGAGTGGTGAATGG, Aldh1a3 F: CCAGT
GTGAGGTAGAGAATGTG, R: GTGTTGAGGGAGGAAAGAAGG,
Aldh1a7 F: TTAGCAGCAGGAGTCTTCAC, R: ACAGGGACAGCCAAA-
TAGC, Aldh8a1 F: ATTCCTCGGTCTGTTCTG, R: TGGCTATCACGG-
TATTCC, b-actin F: TGGCTCCTAGCACCATGA, R: CCACCGATCCA
CACAGAG. The relative efﬁciency of the primers for Aldh1a1,
Aldh1a2 and Ald1b1 was calculated by plotting the threshold
cycle (Ct) as a function of log 10 concentration of the target
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the cDNAs of the three genes (Sup. Fig. 1 x-axis is plotted as a
function of the –log pMol of target sequence). The slope of the
trend line generated is a function of PCR efﬁciency, with a slope of
3.32 indicating 100% efﬁciency (Ballester et al., 2004). Linear
regression analysis showed very good correlation coefﬁcients and
indicated that efﬁciency (Ballester et al., 2004) of the three primer
pairs was high and very similar (Sup. Fig. 1).
In situ antisense RNA hybridization
To generate an Aldh1b1 riboprobe plasmid, cDNA was gener-
ated from Ngn3 expressing ESTetOn/Ngn3 derived pancreas pro-
genitor cells (Seraﬁmidis et al., 2008) and PCR ampliﬁcation
(annealing temperature 61 1C, 35 cycles) using speciﬁc forwardFig. 1. Aldh1b1 is expressed in the pancreatic buds in a Pdx1 dependent manner. (A and
dorsal and ventral pancreatic buds (dp and vp, respectively) at 9.5 dpc (arrows in A) mark
Combined in situ hybridization for Aldh1b1 expression and PDX1 immunostaining sho
ALDH1B1, E-CADHERIN and PDX1 or ISL1. Both ALDH1B1 and PDX1 proteins are prese
completely lost in 9.5 dpc Pdx1 null embryos (E and F). In E and F mesenchymal cells
ALDH1B1, E-CADHERIN and PDX1 or ISL1. ALDH1B1 and PDX1 proteins continue to
completely lost in 10.5 dpc Pdx1 null embryos (I and J). In I and J mesenchymal cells a(50 GGCGAGTCTAGACTCAAGAGAGTCACC 30) and reverse (50 CAC-
TCTGGATCCAGCCACCG 30) primers incorporating XbaI and BamHI
sites, respectively was employed to amplify a 910 bp fragment of
the Aldh1b1 cDNA. The cDNA was subsequently cloned in the
respective sites of pBS SKþ and the antisense RNA probe was
generated using standard procedures. RNA in situ hybridization
and tyramide signal ampliﬁcation were carried out as described
(Seraﬁmidis et al., 2011).
Mouse embryo pancreas dissections and immunoﬂuorescence
Mouse pancreata were ﬁxed, cryoprotected and cryosectioned
at 12 mm using standard procedures and immunoﬂuorescence
was carried out as described (Seraﬁmidis et al., 2011). Primary
antibodies used were: rabbit anti-ALDH1B1 (1:500) (Stagos et al.,B) In situ whole mount hybridization shows that Aldh1b1 is expressed in both the
ed at the same time point by whole mount immunostaining for PDX1 (arrows in B).
wed co-localization (insert in A). (C–F) Triple immunoﬂuorescence at 9.5 dpc for
nt in the same cells of wt embryos (compare C and D). ALDH1B1 expression was
are marked by ISL1 expression. (G–J) Triple immunoﬂuorescence at 10.5 dpc for
be co-expressed in wt embryos (compare G and H). ALDH1B1 expression was
re marked by Isl1 expression. Scale bars: A (inlet), C–F 50 mm; G–J 100 mm.
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CADHERIN (1:400; Zymed), rat anti-CYTOKERATIN 19 (anti-CK-
19; 1:250; DSHB), mouse anti-INSULIN (1:1000; Sigma), mouse
anti-GLUCAGON (1:500; Sigma), mouse anti-BrdU (1:200 DAKO),
mouse anti-PDX1 (1:300, DSHB), rabbit anti-AMYLASE (1:300,
Sigma), rabbit anti-SOX9 (1:500; Chemicon), PNA-FITC lectin
(1:100, Sigma), DBA-Rhodamine (1:100, Vector Laboratories).
Secondary antibodies were anti-mouse, anti-rabbit, and anti-rat
Alexa-488-, Alexa-633-, and Alexa-568-conjugated goat antibo-
dies (1:500; Molecular Probes).
Organotypic cultures of embryonic pancreata
Dorsal pancreatic buds were dissected at 11.5 dpc and
cultured for 2.5 or 6 days in a drop (40 ml) of DMEM/F12Fig. 2. Aldh1b1 is expressed in tip and trunk pancreas progenitors and expression in the
E-CADHERIN showed that ALDH1B1 is expressed exclusively in the 12.5 dpc pancreatic
for ALDH1B1 and NKX6.1 at 14.5 dpc wt embryonic pancreata showed that most (arro
(E–G) Triple immunoﬂuorescence experiments for ALDH1B1, E-CADHERIN and NGN3 1
NGN3þ (arrows in G). (H–J) Triple immunoﬂuorescence experiments for ALDH1B1, E-C
ALDH1B1 in the trunk is NGN3 dependent (arrowheads in H–J). Scale bars: A and B, C(Gibco) supplemented with penicillin–streptomycin–glutamine
(Gibco) and non-essential amino acids (Gibco). Diethylaminoben-
zaldehyde (DEAB) (Sigma) and/or RA (Sigma) were used at
100 mM or 25 nM respectively and the medium was renewed
daily. BrdU (BD Biosciences) was used at 10 mM 2 h prior to
ﬁxation. Cultured pancreata were processed for immunoﬂuores-
cence on cryosections using standard procedures. All sections
from at least three pancreata for each experimental condition
were used for quantitation. Images for each section were
taken and analyzed as described (Seraﬁmidis et al., 2011)
to determine differentiation corresponding to each pancreatic
lineage as well as BrdU incorporation for the mesenchymal
and epithelial cell populations. Epithelial cells were deﬁned
as E-CADHERINþ and mesenchymal cells as E-CADHERIN
cells.latter is Ngn3 dependent. (A and B) Double immunoﬂuorescence for ALDH1B1 and
epithelium in both the tips and the trunks. (C and D) Double immunoﬂuorescence
ws in D) but not all (arrowheads in D) NKX6.1þ trunk cells were also ALDH1B1þ .
4.5 dpc wt embryonic pancreata showed that all trunk ALDH1B1þ cells were also
ADHERIN and NGN3 at NGN3 null embryonic pancreata showed that expression of
and D, F and G, I and J 50 mm; E and H 100 mm.
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Acute pancreatitis (AP) was induced by six hourly intraper-
itoneal caerulein (Sigma-Aldrich) injections at 50 mg/kg of body
weight in 0.9% NaCl, following a fasting period of 12 h, and
pancreata were harvested 21 h after the last injection. For b cell
ablation, streptozotocin (Sigma-Aldrich) was administered intra-
peritoneally at 50 mg/kg of body weight following 12 h of fasting.
Streptozotocin was dissolved in 50 mM NaCitrate pH 4.5 and was
prepared fresh just before each injection.Fig. 3. Aldh1b1 is strongly expressed in the developing pancreas compared to
other Aldh genes. Real Time PCR in 12.5 and 14.5 dpc wt and 14.5 Ngn3 null
pancreata was performed for all known Raldh genes as well as for Aldh1b1 and the
closely related Aldh2. Aldh1b1 appears to be expressed in higher levels compared
to Aldh1a1 and Aldh1a2. Aldh1b1 and Aldh1a1 expression levels drop in 14.5 dpc
Ngn3 null pancreata in a statistically signiﬁcant manner (*po0.05).Results
Aldh1b1 is expressed in the early pancreatic buds in a Pdx1
dependent manner
We ﬁrst examined whether Aldh1b1 is expressed at the early
bud stages of pancreas development using whole mount in situ
hybridization. At e9.5, Aldh1b1 expression was similar to that of
Pdx1, a homeobox gene expressed in the developing pancreas
anlagen, and was exclusively and speciﬁcally expressed in both
dorsal and ventral pancreatic buds (Fig. 1A, B). Combined Aldh1b1
in situ hybridization with PDX1 immunoﬂuorescence analysis of
transverse sections at the level of the developing pancreatic buds
revealed that Aldh1b1 is expressed in all cells that have no contact
with the mesenchyme (inner cell layers) and some cells of the
external layer of the developing pancreatic buds (Fig. 1A, inset).
Double Aldh1b1 in situ/ALDH1B1 immunoﬂuorescence experi-
ments conﬁrmed antibody speciﬁcity as all ALDH1B1þ cells were
expressing Aldh1b1 (Sup. Fig. 2A and B). Double immunoﬂuores-
cence experiments showed that the mitochondrial ALDH1B1 and
the transcription factor PDX1 were expressed in the same cells at
both 9.5 dpc (Fig. 1C and D) and 10.5 dpc (Fig. 1G and H). Pdx1
expression is dispensable for induction of the pancreatic buds but
absolutely essential for their subsequent development (Jonsson
et al., 1994; Ofﬁeld et al., 1996). We found that Aldh1b1 expres-
sion in the developing pancreatic buds was Pdx1 dependent as its
expression was completely abolished in the Pdx1 null mutants at
both 9.5 dpc (Fig. 1E and F) and 10.5 dpc (Fig. 1I and J). Thus
Aldh1b1 is expressed in the early pancreatic buds that consist of
multipotent pancreas progenitors in a Pdx1-dependent manner.
Aldh1b1 is strongly expressed in the developing pancreatic
epithelium and its expression in the trunk epithelium is Ngn3
dependent
To examine Aldh1b1 expression at subsequent stages of pan-
creas development we performed in situ hybridization and
immunoﬂuorescence experiments at 12.5 and 14.5 dpc. ALDH1B1
expression persisted exclusively at the tips and the trunk of the
developing pancreas epithelium at both stages, with expression
being stronger at the tips. No expression was detected in the
mesenchyme ( Fig. 2A, B and C–G). Tripotent pancreas progenitors
are located at the tips of the pancreatic epithelium up until 13.5
dpc when they become exocrine progenitors (Zhou et al., 2007).
At 14.5 dpc NKX6.1þ endocrine/ductal progenitors and Ngn3þ
endocrine progenitors are located in the trunk. Additionally, the
presence of an NKX6.1þ tripotent progenitor population at the
interface between the tip and trunk territories has been postu-
lated (Kopp et al., 2011a). We found that the majority of NKX6.1þ
cells were also ALDH1B1þ (86%, n¼482). NKX6.1þ cells at the
interface between tips and trunk epithelium were all ALDH1B1þ ,
whereas most, but not all NKX6.1þ cells at the trunk were
ALDH1B1þ (Fig. 2C, D). Aldh1b1 was initially identiﬁed as a gene
downstream of Ngn3. Consistently, all trunk ALDH1B1þ cellswere NGN3þ (Fig. 2E–G) and Aldh1b1 expression in the trunk
was completely and selectively abolished in Ngn3-null pancreata
(Fig. 2H–J). Accordingly, overall levels of Aldh1b1 expression were
decreased in the Ngn3-null pancreata at 14.5 dpc (Fig. 3; Sup.
Table 1). At 16.5 dpc ALDH1B1 expression was restricted at the
tips, where exocrine progenitors are located, and its expression
was completely abolished by the end of the gestation period (data
not shown).
Whereas the role of Aldh1a2 in pancreas bud induction is
through the supply of RA (Martin et al., 2005; Molotkov et al.,
2005), the expression and possible role of other Aldh genes during
subsequent stages of pancreas development remains obscure.
Thus we compared expression levels of Aldh1b1 with expression
levels of (a) Aldh2, a gene encoding an Aldh1b1 related mitochon-
drial ALDH that clears toxic aldehydes (Chen et al., 2008), (b)
Raldh genes encoding enzymes necessary for RA generation in vivo
such as Aldh1a1, Aldh1a2 and Aldh1a3 (Duester, 2008), (c) Aldh1a7,
a gene encoding an enzyme that it may also act to clear toxic
aldehydes (Hsu et al., 1999; Montplaisir et al., 2002) and (d)
Aldh8a1, a gene that may also be encoding an RA generating
enzyme (Lin et al., 2003). At 12.5 dpc only Aldh1b1, and to a lesser
extent Aldh1a2, were expressed to appreciable levels (Fig. 3, Sup
Table 1). At 14.5 dpc expression of both Aldh1a1 and Aldh1b1 was
strongly induced and Aldh1a2 expression was slightly stronger
compared to the earlier stage examined. Expression of Aldh1a2
most likely corresponded to mesenchymal cells (Tulachan et al.,
2003) whereas, based on published data and the results presented
above, Aldh1a1 and Aldh1b1 expression corresponded exclusively
to the developing epithelium (Ostrom et al., 2008; Tulachan et al.,
2003) (Fig. 3, Sup. Table 1). Aldh1b1 expression dropped substan-
tially in the 14.5 dpc Ngn3 null pancreata reﬂecting the loss of the
Aldh1b1 expressing NGN3þ endocrine progenitor cells and con-
ﬁrming that Aldh1b1 expression in the epithelium is partly Ngn3
dependent. Consistent with the epithelial expression of Aldh1a1
and epithelial alterations in the Ngn3 null embryonic pancreata
(Magenheim et al., 2011) its expression also decreased signiﬁ-
cantly in the Ngn3 null pancreata. In contrast, and consistent with
its postulated expression in the mesenchyme (Tulachan et al.,
2003), expression of Aldh1a2 was not affected in the mutants
(Fig. 3, Sup. Table 1). Primer efﬁciency was essentially the same
for Aldh1b1 and Aldh1a1 primer pairs and efﬁciency of the Aldh1a2
primers was only slightly higher (Sup. Fig. 1).
Taken together, the data suggested that Aldh1b1 is expressed
in different pancreas progenitor pools during the expansion
and branching of the pancreatic epithelium. Its expression is
at least comparable and most likely higher than that of Aldh1a1
and deﬁnitely higher than that of Aldh1a2 around the time of
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opment of the pancreatic epithelium.
ALDH activity is implicated in maintaining the progenitor status and
balancing the relative development of the pancreas lineages
To address the role of ALDH enzymatic activity in progenitor
cell expansion and/or cell lineage speciﬁcation during pancreas
development we used drop explant cultures of 11.5 dpc embryo-
nic pancreata. Dorsal pancreata were dissected and cultured in a
drop of deﬁned medium for six days. At the end of that period,
cells representing all three lineages developed reproducibly,
suggesting that this approach could be used to assess the
contribution of the ALDH enzymatic activity in early embryonic
pancreas growth and differentiation. We blocked ALDH activity
by including in the culture medium 100 mM DEAB, a speciﬁc
competitive reversible inhibitor of ALDH enzymes (Marchitti
et al., 2008). At the end of the six-day culture period, quantiﬁca-
tion of the DAPI signal indicated that DEAB treated pancreas
explants (n¼7) were reduced in size by half when compared to
untreated ones (n¼7, po0.05). There was no evidence of exces-
sive cell death (data not shown). To assess whether the size
reduction was due to a reduction in mitotic rate we cultured 11.5
dpc pancreata for a period of 60 h and labeled mitotic cells in the
presence of 10 mM BrdU 2 h prior to ﬁxation. We quantitated
BrdU incorporation in the epithelium (E-CADHERINþ domain)Fig. 4. Blocking of ALDH activity in mouse embryonic pancreas explants reduces mitosi
DEAB treated (B and D) pancreata for E-Cadherin and BrdU showed that BrdU incorporat
reduced in the trunk epithelium of DEAB treated pancreata. Areas marked by squares i
Immunoﬂuorescence in untreated (E) and DEAB treated (F) pancreata showed a drop
untreated (G) and DEAB treated (H) pancreata showed a drop in NGN3 expression fo
treated pancreata. Inclusion of RA further reduced incorporation to levels similar by th
25 mm.compared to the rest of the developing pancreas (E-CADHERIN
domain) by immunoﬂuorescence. BrdU incorporation in the
epithelium of pancreata cultured in the presence of 100 mM DEAB
was preferentially reduced by approximately 15% whereas BrdU
incorporation in the mesenchyme was not affected (Fig. 4A, B and I).
Since DEAB is a universal inhibitor of ALDH activity (Marchitti
et al., 2008), including RALDHs, we assessed whether the decrease
in mitotic cells was due to inhibition of RA generation, by
supplementing the explant cultures with 25 nM RA. Strikingly,
the proliferation rate dropped even further with the addition of
RA, suggesting that the DEAB effect was not through inhibition of
RA generation. Inclusion of both DEAB and RA in the same explant
cultures did not produce additional synergistic effects, suggesting
that they act in independent, parallel pathways (Fig. 4I).
Interestingly, BrdU incorporation in the DEAB treated explants
was concentrated at the developing tips of the epithelium
(Fig. 4A–D) suggesting that loss of ALDH activity could be
affecting preferentially the endocrine and ductal lineages ema-
nating from the trunk epithelium. Accordingly, we then examined
whether the reduction of the mitotic rate in the epithelium and
primarily in the trunk resulted in precocious differentiation and
whether it perturbed the relative balance among pancreas
lineages. We indeed found that after 60 h in culture, expression
of SOX9 was lower and expression of NGN3 was dramatically
lower in treated compared to control pancreata (Fig. 4E–H).
Furthermore, the relative number of the main endocrine cells in the epithelium. (A–D) Double immunoﬂuorescence in untreated (A and C) and
ion apparent in the trunk epithelium of control pancreata (arrows in C) was greatly
n A and B are represented in high magniﬁcation in C and D respectively. (E and F)
in SOX9 expression following DEAB exposure. (G and H) Immunoﬂuorescence in
llowing DEAB exposure. (I) Epithelial BrdU incoroporation was reduced in DEAB
e inclusion of RA alone (po0.02). Scale bars: A–D, E and F, G–J 100 mm; C and D
Fig. 5. Blocking of Aldh activity in mouse embryonic pancreas explants accelerates differentiation and changes the relative linage distribution. (A and B) Double
immunoﬂuorescence for AMYLASE and INSULIN in untreated (A) and DEAB treated (B) pancreata showed an increase in the number of INSULINþ cells (depicted graphically
in E). (C and D) Double immunoﬂuorescence for CK19 and glucagon in untreated (C) and DEAB treated (D) pancreata showed a strong increase in the number of
GLUCAGONþ cells (depicted graphically in E). Scale bars: A–D 100 mm.
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and seven fold respectively, whereas the smaller SOMATOSTATINþ
population was not affected (Fig. 5 and data not shown). Surpris-
ingly, expression levels of the endocrine hormone genes
did not change appreciably in the DEAB treated pancreata suggest-
ing complex effects of ALDHs on endocrine cell maturation.
The number of ductal CK19þ cells also expanded by three fold
(Fig. 5C–E). In contrast, the relative number of amylaseþ cells did
not change (Fig. 5A, B and E). Thus, blocking ALDH enzymatic
activity resulted in a reduction of the mitotic rate, and conse-
quently explant size, and alteration of the relative balance of
pancreatic lineages.
Rare ALDH1B1þ cells persist in the adult pancreas and expand
vigorously in two different models of pancreas injury
Strong Aldh1b1 expression ceases by birth (data not shown).
However, expression persisted in the adult stages in very rare
elongated cells that were PNAþ/DBA (93%, n¼27) suggesting
that they were centroacinar-like cells. We did not detect any
ALDH1B1þ/DBAþ cells (Fig. 6A–C) whereas very few ALDH1B1þ
cells were PNA/DBA (7%, n¼27).
Genetic, surgical or pharmacological insults can induce pan-
creas regeneration characterized by upregulation of the expression
of progenitor markers and variable degrees of tissue repair.
Administration of caerulein results in excessive secretion and
auto-activation of digestive enzymes as well as inﬂammation
leading to extensive death of the acinar cells. Remarkably, the
pancreas is able to recover from such an insult through regeneration
and return to normal histology and function (Jensen et al., 2005;
Strobel et al., 2007). We evaluated the behavior of the rare
centroacinar-like ALDH1B1þ cells in the context of acute pancreatitisinduced by successive caerulein injections. Pancreata were analyzed
for ALDH1B1 expression 21 h after the last injection. Strikingly,
and in contrast to the very low abundance of ALDH1B1þ cells in
untreated adult pancreata (Fig. 6A), the number of ALDH1B1þ cells
expanded approximately 20-fold following caerulein-induced pan-
creatitis (Fig. 6D). Additionally, the percentage of ALDH1B1þ cells
that were either PNAþ/DBAþ or PNA/DBA increased as compared
to untreated controls (to 6% and 14% respectively, n¼86). (Fig. 6D–F
and data not shown). ALDH1B1þ cells did not express either PDX1 or
NKX6.1 (data not shown). However, consistent with the notion that
these were progenitor cells, ALDH1B1þ cells did incorporate BrdU
(Sup. Fig. 3A).
We also investigated whether an insult directed at the endo-
crine compartment had a comparable result. To ablate b cells we
delivered streptozotocin intraperitoneally at 50 mg/kg of body
weight, once per day, for 3 consecutive days and pancreata were
analyzed 14 days after the last injection. Similarly to the caerulein
treated pancreata, the number of ALDH1B1þ cells increased 10-fold
following streptozotocin treatment (Fig. 6G). In contrast to
caerulein treatment, streptozotocin treatment did not appaear
to alter the percentages of ALDH1B1þ cells that were PNAþ/
DBA or PNA/DBA (Fig. 6H, I, K and L). Some ALDH1B1þ cells
did incorporate BrdU suggesting, that at least some ALDH1B1þ
cells retained progenitor status (Sup. Fig. 3B), but ALDH1B1þ cells
were not positive for either PDX1 or NKX6.1 (data not shown).
Remarkably ALDH1B1þ cells were occasionally seen surrounding
b cell depleted islets (Fig. 6J).
Taken together these data showed that very rare ALDH1B1þ
cells persisted in the adult pancreas. The ALDH1B1þ cell popula-
tion expanded greatly following two different insults ablating the
acinar and b cell population suggesting that ALDH1B1 expression
marks stem/progenitor cells in the adult pancreas.
Fig. 6. Very rare ALDH1B1þ cells persist in the adult pancreas but their number expands vastly following either caerulein or streptozotocin insults. (A–C) Triple
immunoﬂuorescence of wt, untreated pancreata showed the presence of rare elongated cells expressing ALDH1B1 (A–C, arrows in A), E-CADHERIN (A and B) and PNA (C).
(D–F) The number of ALDH1B1þ cells expanded by 20-fold in response to acute pancreatitis as shown by triple immunoﬂuorescence for ALDH1B1 (D–F, arrows in D),
E-CADHERIN (D and E) and PNA (F). Most ALDH1B1þ cells were PNAþ (F, arrows) but some were PNA (F, arrowheads). (G–I) The number of ALDH1B1þ cells expanded by
10-fold in response to b cell ablation as shown by triple immunofuorescence for ALDH1B1 (G–I, arrows in G), E-CADHERIN (G and H) and PNA (I). (J–L) ALDH1B1þ cells
occasionally surrounded b cell depleted islets (J, arrows). Occasionally, ALDH1B1þ/DBAþ (K, arrow) or ALDH1B1þ/DBAþ/PNAþ (L, arrow) cells were observed. Scale bars:
A, D, and G 100 mm; B and C, E and F, H and I, J and L 25 mm.
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Deregulation of pancreatic homeostasis can lead to diabetes or
pancreatic cancer, both diseases with very high prevalence and
high associated human cost. Generating insulinogenic b cells from
pluripotent stem cells or inducing pancreas regeneration from
endogenous stem cells to replenish the pool of b cells could
provide new effective treatments for diabetes. The existence of
pancreatic stem cells and their contribution to cancer remains
controversial. In the mouse, putative adult pancreas stem/pro-
genitor cells were isolated as cells with high ALDH activity fromthe centroacinar compartment and had the capacity to generate
endocrine and exocrine cells in culture (Rovira et al., 2010).
Strikingly, experiments in a genetically engineered mouse model
of pancreatic cancer suggested that cells in the same location
might be the cells of origin of pancreatic cancer (Esposito et al.,
2007; Guerra et al., 2007). The identiﬁcation of speciﬁc
marker(s) for these cells may help to devise strategies for b cell
replenishment in diabetes or stopping pancreatic cancer
progression.
Here we report the identiﬁcation of a novel Aldh gene, Aldh1b1,
expressed in the early embryo pancreatic buds and during
M. Ioannou et al. / Developmental Biology 374 (2013) 153–163 161subsequent development in different progenitor pools. Rare
ALDH1B1þ cells persisted in the adult but their number expanded
greatly after pancreas injury targeting either the b cell population
or the acinar cell population. We propose that Aldh1b1 is a
pancreas progenitor marker. The elucidation of its function may
aid in devising strategies to stimulate in vivo expansion and
differentiation of these cells.
The ALDH superfamily consists of proteins with complex
expression patterns and diverse, often unknown, substrates
(Jackson et al., 2011). ALDH catalytic activity, determined by
Aldeﬂuor assay, is being increasingly associated with stem/pro-
genitor cell status (Balber, 2011) but also cancer stem cells (Alison
et al., 2010). Lack of speciﬁc antibodies for distinct ALDH proteins
has not allowed the unequivocal assignment of speciﬁc ALDHs to
distinct stem/progenitor populations. Here we demonstrated that
ALDH1B1 persists in pancreas progenitor pools during develop-
ment and in rare cells in the adult pancreas. A possible role of
ALDHs in stem/progenitor cells may relate to the regulation of
reactive oxygen species (ROS) levels. Stem and progenitor cells
need to precisely regulate levels of ROS, which may damage DNA
but also regulate cell proliferation and differentiation in some
types of tissue stem cells (Kobayashi and Suda, 2012). Oxidative
stress resulting from the accumulation of ROS can be detrimental
to stem cells as it may result to accumulation of DNA damage
thus permanently impairing the function of terminally differen-
tiated descendant cells. Thus, systems that neutralize ROS should
be ﬁne tuned according to the requirements of different speciﬁc
stem cell type and ALDHs are part of the cellular response that
protects against oxidative stress (Black et al., 2012; Brocker et al.,
2010). Under physiological conditions, the principal source of ROS
are the mitochondria (Balaban et al., 2005) and therefore, in
pancreas progenitors, the mitochondrial ALDH1B1 could be par-
ticipating in reducing the load of toxic aldehydes, possibly in
conjunction with the cytosolic ALDH1A1, to levels compatible
with stem/progenitor status.
So far, three Aldh genes have been found to be expressed
during pancreas development. Aldh1a2 (aka Raldh2) encodes the
main retinoic acid generating enzyme and plays a key role in the
induction of the dorsal pancreatic bud in the mouse. At early
stages it is expressed in the dorsal pancreatic mesenchyme,
and signals to adjacent mesenchymal cells to induce Isl1 and
endodermal cells to induce Prox1 and Pdx1 and acquire dorsal
pancreatic bud fates. Lack of functional Aldh1a2 results in loss of
the dorsal pancreatic bud and this can be rescued by maternal
supplementation of RA (Martin et al., 2005; Molotkov et al., 2005).
This function is evolutionarily conserved as loss of function
mutations of the zebraﬁsh Aldh1a2 resulted in a similar pheno-
type (Stafford and Prince, 2002). During subsequent developmen-
tal stages, Aldh1a2 is expressed at low levels in the mesenchyme
but not in the developing epithelium (Tulachan et al., 2003).
Aldh1a1 (aka Raldh1) is detected in the branching epithelium
(Ostrom et al., 2008; Tulachan et al., 2003). Aldh1a1 null mice
were viable and fertile and showed no overt pancreas related
phenotype (Fan et al., 2003; Matt et al., 2005). Thus whereas RA is
indispensable for the induction of the pancreas anlagen, its
involvement in subsequent stages of pancreas development
remains to be demonstrated. Our ﬁndings demonstrate that
another Aldh gene, Aldh1b1, may be implicated in pancreas
development. At 9.5 dpc it is exclusively and strongly expressed
in both pancreatic buds. At subsequent stages its expression
remains strong and, based on qPCR analysis, stronger than either
Aldh1a1 or Ald1a2. Aldh1b1 nulls are viable and fertile with no
obvious pancreas associated defects.
Two models may account for the role of Aldh1b1 and Aldh1a1
in the development of the pancreatic epithelium. One postulates a
sequential role for the corresponding proteins; the ﬁrst promotingthe progenitor state via as yet unknown mechanisms, and the
second promoting differentiation, possibly through the local
generation of retinoic acid. Supplementation of the explant
cultures with physiological concentrations of RA promoted differ-
entiation but this ﬁnding does not necessarily imply a role of RA
in vivo. The other model would postulate that the two proteins
overlap functionally, possibly participating in the ROS detoxiﬁca-
tion process. The inactivation of all ALDHs in pancreatic
explant cultures by DEAB suggested that the net effect of ALDH
activity is to promote the progenitor state, but it cannot exclude
the possibility that ALDH1A1 and ALDH1B1 may function in
opposing capacities to balance progenitor pool maintenance and
differentiation. Elucidating the developmental mechanisms con-
trolling this balance will provide valuable cues for the efﬁcient
differentiation of PS derived pancreas progenitors into mature
endocrine cells. Given the absence of any overt pancreas asso-
ciated phenotype in either the Aldh1a1 or the Aldh1b1 null
mutants, we favor the hypothesis that these two ALDHs overlap
functionally.
It was surprising to ﬁnd that qPCR reactions did not detect
appreciable changes in the endocrine hormone transcripts in
control and DEAB treated pancreata. There could be several
explanations for this result. It is possible that although the
numbers of endocrine cells are increased, the amount of tran-
script produced per cell may be reduced in response to DEAB
treatment. Alternatively, blocking ALDH activity may alter endo-
crine cell maturation either by increasing the rates of hormone
translation from pre-existing mRNA transcripts, or by stabilizing
the already synthesized hormones and preventing their degrada-
tion. The exact mechanisms by which ALDHs exert their effects on
endocrine cell maturation remain to be elucidated.
The existence of facultative stem/progenitor cells in the adult
pancreas remains controversial. Extensive studies using lineage
tracing have not pinpointed such a cell population. A possible
caveat of these studies is that mostly markers of mature cells have
been used for the lineage tracing, possibly excluding specialized
progenitor cells. On the other hand combined expression of
several transcription factors may deﬁne this subpopulation,
making it very difﬁcult to detect unequivocally (Kopp et al.,
2011a). Recently, putative adult pancreas stem/progenitor cells
were isolated from the interface of ducts with the exocrine
compartment using FACS and the Aldeﬂuor ﬂuorescence assay
that labels cells with ALDH enzymatic activity. These cells had the
capacity to generate endocrine and exocrine cells in vitro and
were shown to express certain stem/progenitor markers and
three Aldh genes, namely Aldh1a1/a2/a7. The number of these
cells greatly increased after caerulein treatment that induces
pancreatitis and sets in motion a regenerative response (Rovira
et al., 2010). Here we show the population of Aldh1b1þ cells
expands greatly following injuries directed against either the
endocrine or acinar compartments. In both cases cells are pro-
liferative and mostly E-cadherinþ/PNAþ suggesting an origin
from the acinar compartment. The relatively fast appearance of
Aldh1b1þ cells following injury, particularly after caerulein
treatment, suggests that they originate from cells that have
dedifferentiated, rather than the preexisting small population of
Aldh1b1þ cells. Furthermore, the expansion of this population in
two different models of pancreatic injury suggests that Aldh1b1 is
part of a general injury response in the adult pancreas and it will
be important to identify the signals driving this expansion.
Intriguingly, following caerulein treatment, and in contrast to
streptozotocin treatment, the number of ALDH1B1þ that were
either DBAþ/PNAþ or DBA/PNA appeared increased, suggest-
ing a differential response of ALDH1B1þ cells to distinct insults.
To evaluate the relative importance of ALDHs in pancreas pro-
genitors and regeneration it will be important to assess which, if
M. Ioannou et al. / Developmental Biology 374 (2013) 153–163162any, ALDH activity is required for the multipotency of the ALDH
active cells and for the pancreas regenerative response.
ALDH1B1 appears unique among other ALDHs because it may
continuously and speciﬁcally mark stem/progenitor cells in the
developing and adult pancreas. Interestingly, ALDH1B1 has been
identiﬁed as a potential colon cancer biomarker (Chen et al.,
2011). Often, the same signaling pathways used in development
are utilized during regeneration but also for cancer stem cell
propagation. Having a single gene speciﬁcally expressed in stem
cells during development, the mature organ and development of
cancer will allow for the isolation and comparative analysis of the
corresponding populations. This, combined with functional stu-
dies of Aldh1b1, may accelerate the discovery of approaches to
enhance pancreas regeneration and halt the progression of
pancreatic cancer.Acknowledgments
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